IRWD שולי הרווח הגולמי Ironwood Pharmaceuticals

סמל תאגידי ולוגו של ironwoodpharma.com (IRWD)

Ironwood Pharmaceuticals management is focusing on expanding its market share of GI drugs to increase cash flows. High sales of the flagship product provide excess liquidity. The gross profit margin on this chart visualizes cost efficiency, where the value 99.60 describes the current level. The business relies on non-cyclical demand, which guarantees profit stability regardless of economic shocks.

שולי רווח גולמי: Ironwood Pharmaceuticals (IRWD) עבור 04.07.2022 - 20.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת Ironwood Pharmaceuticals, Inc. (IRWD)

- מחיר ותחזית קונצנזוס למחירים:
הערכת שווי פונדמנטלית:Ironwood Pharmaceuticals (IRWD)
מוצרים מיוצרים של ironwoodpharma.com

Gross margin measures the efficiency of the operating cycle by determining the portion of revenue remaining after covering direct production costs. An analysis of the adjusted gross margin allows for tracking the stability of the pricing policy of Ironwood Pharmaceuticals (IRWD), confirming the high profitability of the drug Linzess due to inelastic demand and robust patent protection of key assets in the gastrointestinal disease segment.